Literature DB >> 29565520

Adverse Events Associated with Immune Checkpoint Blockade.

Bharat Kumar1,2, Zuhair Ballas1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29565520      PMCID： PMC6433406          DOI： 10.1056/NEJMc1801663

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

Review 1.  Checkpoint Inhibitors.

Authors:  Lucie Heinzerling; Enrico N de Toni; Georg Schett; Gheorghe Hundorfean; Lisa Zimmer
Journal:  Dtsch Arztebl Int       Date:  2019-02-22       Impact factor: 5.594

Review 2.  Neurotoxicity and safety of the rechallenge of immune checkpoint inhibitors: a growing issue in neuro-oncology practice.

Authors:  M Villagrán-García; R Velasco
Journal:  Neurol Sci       Date:  2022-02-17       Impact factor: 3.830

Review 3.  Mechanisms Driving Immune-Related Adverse Events in Cancer Patients Treated with Immune Checkpoint Inhibitors.

Authors:  David J Lee; Howard J Lee; Jocelyn R Farmer; Kerry L Reynolds
Journal:  Curr Cardiol Rep       Date:  2021-07-01       Impact factor: 2.931

Review 4.  Adverse events induced by immune checkpoint inhibitors.

Authors:  Ana Luisa Perdigoto; Harriet Kluger; Kevan C Herold
Journal:  Curr Opin Immunol       Date:  2021-02-25       Impact factor: 7.486

Review 5.  Holistic Approach to Immune Checkpoint Inhibitor-Related Adverse Events.

Authors:  Remo Poto; Teresa Troiani; Gjada Criscuolo; Giancarlo Marone; Fortunato Ciardiello; Carlo Gabriele Tocchetti; Gilda Varricchi
Journal:  Front Immunol       Date:  2022-03-30       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.